If affordable and feasible, therapeutic drug monitoring is recommended before making any changes in biologic treatment. The addition of an immunomodulator after IFX monotherapy that was complicated by ...
A complete SICUS investigation was performed in all evaluated patients after the ingestion of 375 mL of macrogol solution and none experienced any adverse event. According to the study protocol the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results